This is a Validated Antibody Database (VAD) review about bovine RB1, based on 70 published articles (read how Labome selects the articles), using RB1 antibody in all methods. It is aimed to help Labome visitors find the most suited RB1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
RB1 synonym: P105-RB; PP110; RB11

Cell Signaling Technology
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 5b). Pharmaceutics (2022) ncbi
mouse monoclonal (4H1)
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; tbl 1
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309S) was used in immunohistochemistry - paraffin section on human samples at 1:250 (tbl 1). ESMO Open (2022) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology RB1 antibody (Cell Signal, 9309) was used in western blot on human samples (fig 2d). Clin Transl Med (2021) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 9309) was used in western blot on human samples (fig 2c). BMC Cancer (2021) ncbi
mouse monoclonal (4H1)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 2b
Cell Signaling Technology RB1 antibody (CST, 9309) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2b). Nat Commun (2021) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 6a
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 6a). Oncogenesis (2021) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig s2a
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig s2a). Breast Cancer Res (2021) ncbi
mouse monoclonal (4H1)
  • western blot; mouse; loading ...; fig 4e
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on mouse samples (fig 4e). Biol Open (2021) ncbi
mouse monoclonal (4H1)
  • western blot; mouse; 1:2000; loading ...; fig 4g
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on mouse samples at 1:2000 (fig 4g). elife (2020) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig s5h
Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 9309) was used in western blot on human samples (fig s5h). Cell (2020) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 2i
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 2i). Mol Cancer (2020) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig 4f
Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 9309S) was used in western blot on human samples at 1:1000 (fig 4f). Cell Death Dis (2019) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig 5b
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309S) was used in western blot on human samples at 1:1000 (fig 5b). Mol Cancer Ther (2019) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology RB1 antibody (CST, 9309) was used in western blot on human samples (fig 1e). Cell Rep (2019) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 4b). Br J Cancer (2019) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 4a). J Exp Med (2019) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig e1b
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig e1b). Nature (2019) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:2000; loading ...; fig e3b
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:2000 (fig e3b). Nat Med (2019) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples (fig 1c). Oncotarget (2018) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; fig 5a
Cell Signaling Technology RB1 antibody (New England Biolab, 9309) was used in western blot on human samples at 1:1000 (fig 5a). Oncogene (2018) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig 7b
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:1000 (fig 7b). Lab Invest (2019) ncbi
mouse monoclonal (4H1)
  • other; human; loading ...; fig 4c
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:3000; loading ...; fig 7a
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:3000 (fig 7a). Nat Commun (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig s3
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:1000 (fig s3). Nat Commun (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 1e). ACS Chem Biol (2018) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 2b). Tumour Biol (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:2000; loading ...; fig 5j, 5l
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:2000 (fig 5j, 5l). Gut (2018) ncbi
mouse monoclonal (4H1)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology RB1 antibody (CST, 9309) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; fig 5a
In order to determine the contribution of NOX4 to the development of pancreatic ductal adenocarcinoma, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:1000 (fig 5a). Nat Commun (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 5h
Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in western blot on human samples (fig 5h). Nat Commun (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 8a
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 8a). J Cell Physiol (2017) ncbi
mouse monoclonal (4H1)
  • western blot; mouse; 1:1000; loading ...; fig S1h
Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in western blot on mouse samples at 1:1000 (fig S1h). Nat Commun (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 2a
In order to identify pathways that contribute to resistance to the antiandrogen drug enzalutamide, Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 9309) was used in western blot on human samples (fig 2a). Science (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 9309) was used in western blot on human samples . Cell Syst (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 1c
In order to assess the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of colorectal cancer, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 1c). Oncotarget (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:2000; loading ...; fig 5a
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:2000 (fig 5a). Cell Cycle (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 6e
In order to determine the rotavirus NSP1-host protein interaction network, Cell Signaling Technology RB1 antibody (CST, 4H1) was used in western blot on human samples (fig 6e). PLoS Pathog (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig 1d
Cell Signaling Technology RB1 antibody (cell signalling, 9309) was used in western blot on human samples at 1:1000 (fig 1d). Oncotarget (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 3
In order to test if interactions between pUL97 and other viral proteins can be detected by mass spectrometry-based approaches, Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples (fig 3). Viruses (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 6b
In order to assess the anticancer properties of 3',4',5'-trimethoxy-5-chloro-isatinylchalcone, Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples (fig 6b). PLoS ONE (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig 3f
In order to elucidate the role of NOTCH1 in oncogene-induced senescence, Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in western blot on human samples at 1:1000 (fig 3f). Nat Cell Biol (2016) ncbi
mouse monoclonal (4H1)
  • chromatin immunoprecipitation; human; fig 3
  • western blot; human; fig 2
Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in chromatin immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 2). elife (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 6
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 6). Genome Biol (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 3
Cell Signaling Technology RB1 antibody (Cell Signaling Tech, 9309S) was used in western blot on human samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 4c
In order to elucidate how p21 is suppressed in embryonic stem cells, Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples (fig 4c). Sci Rep (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:2000; fig s5
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309P) was used in western blot on human samples at 1:2000 (fig s5). Nat Commun (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 3
In order to study inhibition in hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer cells with acquired resistance to Paclitaxel by effects of CDK4/6, Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 9309) was used in western blot on human samples (fig 3). J Cancer (2016) ncbi
mouse monoclonal (4H1)
  • immunoprecipitation; human; fig 1
  • western blot; human; fig 1
In order to analyze enhancement of binding with CDK2 and phosphorylation at early G1 phase by SUMOylationn of Rb, Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in immunoprecipitation on human samples (fig 1) and in western blot on human samples (fig 1). Cell Cycle (2016) ncbi
mouse monoclonal (4H1)
  • western blot; mouse; 1:1000; loading ...; fig s10b
In order to use naked mole-rat-induced pluripotent stem cells to study mechanisms of cancer resistance, Cell Signaling Technology RB1 antibody (CST, 9,309) was used in western blot on mouse samples at 1:1000 (fig s10b). Nat Commun (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 4
In order to study attenuation of AKT signaling to promote internal ribosome entry site-dependent translation and expression of c-MYC by the human papillomavirus 16 E7 oncoprotein, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 4). J Virol (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 5
Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig s3e
Cell Signaling Technology RB1 antibody (CST, 9309) was used in western blot on human samples (fig s3e). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig st3
In order to study the DNA damage response in senescent epithelial cells, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:1000 (fig st3). Nat Commun (2016) ncbi
mouse monoclonal (4H1)
  • western blot; rat; fig 8a
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on rat samples (fig 8a). J Diabetes Res (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 4
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 4). Cell Cycle (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 3d
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 3d). PLoS ONE (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 7
In order to analyze sensitivity to the cyclin D1/CDK4 pathway inhibition in Ewing sarcoma by a chemical genomic, functional, and super-enhancer screening, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 7). Oncotarget (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:500; loading ...; fig 10a
Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples at 1:500 (fig 10a). PLoS ONE (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 2
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 2). Mol Biol Cell (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in western blot on human samples at 1:1000 (fig 1). PLoS Pathog (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:2000
In order to study the regulation of the human papillomavirus 16 oncoprotein expression, Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 4H1) was used in western blot on human samples at 1:2000. J Virol (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 1
Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples (fig 1). J Virol (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig 5g
Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 4H1) was used in western blot on human samples at 1:1000 (fig 5g). Nat Commun (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 4f
In order to study the role of N-terminal acetylation in Ogden syndrome, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 4f). Hum Mol Genet (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 2d
In order to study the effects of cyclin-dependent kinase 7 inhibitors on MYC proteins, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 2d). Cell (2014) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:1000. Cell (2014) ncbi
mouse monoclonal (4H1)
  • western blot; human
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309P) was used in western blot on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (4H1)
  • western blot; human
Cell Signaling Technology RB1 antibody (Cell signaling, 4H1) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 5
Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 9309) was used in western blot on human samples (fig 5). Oncogenesis (2012) ncbi
mouse monoclonal (4H1)
  • western blot; human
Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples . Cancer Res (2013) ncbi
Articles Reviewed
  1. Deshmukh D, Xu J, Yang X, Shimelis H, Fang S, Qiu Y. Regulation of p27 (Kip1) by Ubiquitin E3 Ligase RNF6. Pharmaceutics. 2022;14: pubmed publisher
  2. Simbolo M, Centonze G, Ali G, Garzone G, Taormina S, Sabella G, et al. Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities. ESMO Open. 2022;7:100308 pubmed publisher
  3. Zhang Y, He L, Huang L, Yao S, Lin N, Li P, et al. Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway. Clin Transl Med. 2021;11:e503 pubmed publisher
  4. Moon S, Lee H, Kim S, Hong J, Chun S, Lee H, et al. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells. BMC Cancer. 2021;21:931 pubmed publisher
  5. Li R, Yang Z, Shao F, Cheng H, Wen Y, Sun S, et al. Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes. Nat Commun. 2021;12:3785 pubmed publisher
  6. Nagamura Y, Miyazaki M, Nagano Y, Yuki M, Fukami K, Yanagihara K, et al. PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification. Oncogenesis. 2021;10:25 pubmed publisher
  7. Pairawan S, Zhao M, Yuca E, Annis A, Evans K, Sutton D, et al. First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models. Breast Cancer Res. 2021;23:29 pubmed publisher
  8. Qiao F, Law H, Krieger K, Clement E, Xiao Y, Buckley S, et al. Ctdp1 deficiency leads to early embryonic lethality in mice and defects in cell cycle progression in MEFs. Biol Open. 2021;10: pubmed publisher
  9. Au C, Furness J, Britt K, Oshchepkova S, Ladumor H, Soo K, et al. Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531. elife. 2020;9: pubmed publisher
  10. Koundouros N, Karali E, Tripp A, Valle A, Inglese P, Perry N, et al. Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived Eicosanoids. Cell. 2020;181:1596-1611.e27 pubmed publisher
  11. Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, et al. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer. 2020;19:28 pubmed publisher
  12. Tan P, Xu Y, Du Y, Wu L, Guo B, Huang S, et al. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Cell Death Dis. 2019;10:794 pubmed publisher
  13. Mao N, Gao D, Hu W, Hieronymus H, Wang S, Lee Y, et al. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes. Mol Cancer Ther. 2019;18:1577-1586 pubmed publisher
  14. Cornell L, Wander S, Visal T, Wagle N, Shapiro G. MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance. Cell Rep. 2019;26:2667-2680.e7 pubmed publisher
  15. Dufour F, Silina L, Neyret Kahn H, Moreno Vega A, Krucker C, Karboul N, et al. TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer. Br J Cancer. 2019;120:555-564 pubmed publisher
  16. Chen H, Poran A, Unni A, Huang S, Elemento O, Snoeck H, et al. Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells. J Exp Med. 2019;216:674-687 pubmed publisher
  17. Nassour J, Radford R, Correia A, Fusté J, Schoell B, Jauch A, et al. Autophagic cell death restricts chromosomal instability during replicative crisis. Nature. 2019;565:659-663 pubmed publisher
  18. Sharifnia T, Wawer M, Chen T, Huang Q, Weir B, Sizemore A, et al. Small-molecule targeting of brachyury transcription factor addiction in chordoma. Nat Med. 2019;25:292-300 pubmed publisher
  19. Bernal A, Moltó Abad M, Dominguez D, Tusell L. Acute telomere deprotection prevents ongoing BFB cycles and rampant instability in p16INK4a-deficient epithelial cells. Oncotarget. 2018;9:27151-27170 pubmed publisher
  20. Brough R, Gulati A, Haider S, Kumar R, Campbell J, Knudsen E, et al. Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer. Oncogene. 2018;37:5701-5718 pubmed publisher
  21. Wang Y, Sun H, Kumar S, Puerta M, Jo H, Rezvan A. ZBTB46 is a shear-sensitive transcription factor inhibiting endothelial cell proliferation via gene expression regulation of cell cycle proteins. Lab Invest. 2019;99:305-318 pubmed publisher
  22. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  23. Fang J, Coon B, Gillis N, Chen Z, Qiu J, Chittenden T, et al. Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat Commun. 2017;8:2149 pubmed publisher
  24. Oldrini B, Hsieh W, Erdjument Bromage H, Codega P, Carro M, Curiel García A, et al. EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer. Nat Commun. 2017;8:2035 pubmed publisher
  25. Umaña A, Iwahori S, Kalejta R. Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk). ACS Chem Biol. 2018;13:189-199 pubmed publisher
  26. Paculova H, Kramara J, Simečková S, Fedr R, Soucek K, Hylse O, et al. BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors. Tumour Biol. 2017;39:1010428317727479 pubmed publisher
  27. Chong I, Aronson L, Bryant H, Gulati A, Campbell J, Elliott R, et al. Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer. Gut. 2018;67:1780-1792 pubmed publisher
  28. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  29. Ju H, Ying H, Tian T, Ling J, Fu J, Lu Y, et al. Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Nat Commun. 2017;8:14437 pubmed publisher
  30. Li Z, Ivanov A, Su R, Gonzalez Pecchi V, Qi Q, Liu S, et al. The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies. Nat Commun. 2017;8:14356 pubmed publisher
  31. Squillaro T, Antonucci I, Alessio N, Esposito A, Cipollaro M, Melone M, et al. Impact of lysosomal storage disorders on biology of mesenchymal stem cells: Evidences from in vitro silencing of glucocerebrosidase (GBA) and alpha-galactosidase A (GLA) enzymes. J Cell Physiol. 2017;232:3454-3467 pubmed publisher
  32. Liu T, Yu J, Deng M, Yin Y, Zhang H, Luo K, et al. CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. Nat Commun. 2017;8:13923 pubmed publisher
  33. Mu P, Zhang Z, Benelli M, Karthaus W, Hoover E, Chen C, et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science. 2017;355:84-88 pubmed publisher
  34. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  35. Vakana E, Pratt S, Blosser W, Dowless M, Simpson N, Yuan X, et al. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. Oncotarget. 2017;8:9251-9266 pubmed publisher
  36. Zimmermann M, Arachchige Don A, Donaldson M, Patriarchi T, Horne M. Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival. Cell Cycle. 2016;15:3278-3295 pubmed
  37. Ding S, Mooney N, Li B, Kelly M, Feng N, Loktev A, et al. Comparative Proteomics Reveals Strain-Specific β-TrCP Degradation via Rotavirus NSP1 Hijacking a Host Cullin-3-Rbx1 Complex. PLoS Pathog. 2016;12:e1005929 pubmed publisher
  38. Krepler C, Xiao M, Samanta M, Vultur A, Chen H, Brafford P, et al. Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma. Oncotarget. 2016;7:71211-71222 pubmed publisher
  39. Steingruber M, Kraut A, Socher E, Sticht H, Reichel A, Stamminger T, et al. Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins. Viruses. 2016;8: pubmed publisher
  40. Cao L, Zhang L, Zhao X, Zhang Y. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0161025 pubmed publisher
  41. Hoare M, Ito Y, Kang T, Weekes M, Matheson N, Patten D, et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat Cell Biol. 2016;18:979-92 pubmed publisher
  42. Hossain M, Stillman B. Opposing roles for DNA replication initiator proteins ORC1 and CDC6 in control of Cyclin E gene transcription. elife. 2016;5: pubmed publisher
  43. Nelson D, Jaber Hijazi F, Cole J, Robertson N, Pawlikowski J, Norris K, et al. Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability. Genome Biol. 2016;17:158 pubmed publisher
  44. Chen Z, Wang Z, Pang J, Yu Y, Bieerkehazhi S, Lu J, et al. Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Sci Rep. 2016;6:29090 pubmed publisher
  45. Itahana Y, Zhang J, Göke J, Vardy L, Han R, Iwamoto K, et al. Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells. Sci Rep. 2016;6:28112 pubmed publisher
  46. Hong A, Tseng Y, Cowley G, Jonas O, Cheah J, Kynnap B, et al. Integrated genetic and pharmacologic interrogation of rare cancers. Nat Commun. 2016;7:11987 pubmed publisher
  47. Trapé A, Liu S, Cortés A, Ueno N, Gonzalez Angulo A. Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel. J Cancer. 2016;7:947-56 pubmed publisher
  48. Meng F, Qian J, Yue H, Li X, Xue K. SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase. Cell Cycle. 2016;15:1724-32 pubmed publisher
  49. Miyawaki S, Kawamura Y, Oiwa Y, Shimizu A, Hachiya T, Bono H, et al. Tumour resistance in induced pluripotent stem cells derived from naked mole-rats. Nat Commun. 2016;7:11471 pubmed publisher
  50. Strickland S, Vande Pol S. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC. J Virol. 2016;90:5611-5621 pubmed publisher
  51. Nakayama R, Zhang Y, Czaplinski J, Anatone A, Sicinska E, Fletcher J, et al. Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma. Oncotarget. 2016;7:16581-92 pubmed publisher
  52. Cott C, Thuenauer R, Landi A, Kühn K, Juillot S, Imberty A, et al. Pseudomonas aeruginosa lectin LecB inhibits tissue repair processes by triggering β-catenin degradation. Biochim Biophys Acta. 2016;1863:1106-18 pubmed publisher
  53. Nassour J, Martien S, Martin N, Deruy E, Tomellini E, Malaquin N, et al. Defective DNA single-strand break repair is responsible for senescence and neoplastic escape of epithelial cells. Nat Commun. 2016;7:10399 pubmed publisher
  54. Draney C, Hobson A, Grover S, Jack B, Tessem J. Cdk5r1 Overexpression Induces Primary β-Cell Proliferation. J Diabetes Res. 2016;2016:6375804 pubmed publisher
  55. Adam M, Matt S, Christian S, Hess Stumpp H, Haegebarth A, Hofmann T, et al. SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status. Cell Cycle. 2015;14:3734-47 pubmed publisher
  56. Kim Y, Chen C, Bolton E. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells. PLoS ONE. 2015;10:e0138286 pubmed publisher
  57. Kennedy A, Vallurupalli M, Chen L, Crompton B, Cowley G, Vazquez F, et al. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma. Oncotarget. 2015;6:30178-93 pubmed publisher
  58. Thoompumkal I, Subba Rao M, Kumaraswamy A, Krishnan R, Mahalingam S. GNL3L Is a Nucleo-Cytoplasmic Shuttling Protein: Role in Cell Cycle Regulation. PLoS ONE. 2015;10:e0135845 pubmed publisher
  59. Sadaie M, Dillon C, Narita M, Young A, Cairney C, Godwin L, et al. Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition. Mol Biol Cell. 2015;26:2971-85 pubmed publisher
  60. Honegger A, Schilling D, Bastian S, Sponagel J, Kuryshev V, Sultmann H, et al. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog. 2015;11:e1004712 pubmed publisher
  61. McFarlane M, MacDonald A, Stevenson A, Graham S. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35). J Virol. 2015;89:5276-87 pubmed publisher
  62. VanDeusen H, Kalejta R. The retinoblastoma tumor suppressor promotes efficient human cytomegalovirus lytic replication. J Virol. 2015;89:5012-21 pubmed publisher
  63. The I, Ruijtenberg S, Bouchet B, Cristobal A, Prinsen M, van Mourik T, et al. Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells. Nat Commun. 2015;6:5906 pubmed publisher
  64. Myklebust L, Van Damme P, Støve S, Dörfel M, Abboud A, Kalvik T, et al. Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects. Hum Mol Genet. 2015;24:1956-76 pubmed publisher
  65. Chipumuro E, Marco E, Christensen C, Kwiatkowski N, Zhang T, Hatheway C, et al. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell. 2014;159:1126-1139 pubmed publisher
  66. Gao D, Vela I, Sboner A, Iaquinta P, Karthaus W, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159:176-187 pubmed publisher
  67. Liao Y, Lin T, Chen C, Lin S, Au L. The antileukemia activity of natural product HQ17(3) is possibly associated with downregulation of miR-17-92 cluster. Biomed Res Int. 2014;2014:306718 pubmed publisher
  68. Negishi M, Wongpalee S, Sarkar S, Park J, Lee K, Shibata Y, et al. A new lncRNA, APTR, associates with and represses the CDKN1A/p21 promoter by recruiting polycomb proteins. PLoS ONE. 2014;9:e95216 pubmed publisher
  69. Sappino A, Buser R, Seguin Q, Fernet M, Lesne L, Gumy Pause F, et al. The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage. Oncogenesis. 2012;1:e7 pubmed publisher
  70. Burkhardt L, Fuchs S, Krohn A, Masser S, Mader M, Kluth M, et al. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. Cancer Res. 2013;73:2795-805 pubmed publisher